During the past decade, Hyogo Cancer Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hyogo Cancer Center" #1 collaborator was "Korean Gynecologic Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hyogo Cancer Center" are "Gastric Cancer" (2 trials), "Gastroesophageal Junction Adenocarcinoma" (2 trials), "Colorectal Cancer (CRC)" (1 trials), "Epithelial Ovarian Cancer" (1 trials) and "KRAS p, G12c Mutated /Advanced Metastatic NSCLC" (1 trials). Many other conditions were trialed in "Hyogo Cancer Center" in a lesser frequency.

Most popular intervention types in "Hyogo Cancer Center" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bemarituzumab" (2 trials), "Placebo" (2 trials), "mFOLFOX6" (2 trials), "AMG 510" (1 trials) and "Docetaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hyogo Cancer Center" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hyogo Cancer Center". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hyogo Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hyogo Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".